MedAI Verdict

AI Radiology

Editorial illustration: a chest radiograph alongside a magnifying glass highlighting flagged regions in blue.

Cleerly vs Elucid

All comparisons
49/ 100

Cleerly

30/ 100

Elucid

Scores are legacy evidence and documentation scores, not product-performance ratings. How it is computed

Coronary plaque on CCTA, billed under Category I CPT 75577 since January 2026, is the ground these two share. Medicare pays the performing site about $1,012 nationally for it in imaging centers, and Elucid's own per-scan fee is unpublished. Cleerly adds ischemia likelihood through Cleerly ISCHEMIA, PowerScribe integration, and Cleerly Plaque (K261210, July 2026).

Elucid's PlaqueIQ (K241524, September 2024) works as a service. Per the 2024 release, trained analysts segment a 3D model of the arteries, and turnaround is unpublished. The Lesion Inspection Tool, on sale since April 2026, covers coronary and carotid plaque. Elucid's FFR-CT analysis is pending FDA review, and the FDA record frames the cleared claim as plaque quantification to support clinicians.

Ischemia likelihood from the same scan is a reason to choose Cleerly, and on that need Elucid loses. Practices that also want carotid plaque read and will send images out are Elucid's customers.

Radiology · Reviewed November 1, 2026

On this page
Cleerly logo

Cleerly

by Cleerly

AI-driven CCTA plaque quantification + CAD staging.

Elucid logo

Elucid

by Elucid Bioimaging

PlaqueIQ analyzes coronary plaque on CT angiograms, with FDA 510(k) clearances in September 2024 and September 2026.

When to pick each one

Cleerly

  • Ischemia likelihood from the same CCTA, Cleerly ISCHEMIA K231335
  • PowerScribe integration for reporting
Read the full Cleerly review

Elucid

  • PlaqueIQ cleared September 2024, second 510(k) September 2026
  • Lesion Inspection Tool for coronary and carotid plaque
Read the full Elucid review

Score

Each row shows points earned of points available under the published rubric.

Cleerly

49of 100

Elucid

30of 100
Score by dimension for Cleerly and Elucid
DimensionCleerlyElucidDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers7.3 / 18.20 / 18.2+7.3
RCT / meta-analysis / systematic review3.9 / 7.80 / 7.8+3.9
Funding & adoption signal6 / 123 / 12+3
Pricing transparency2.5 / 52.5 / 50

Scroll horizontally to see every column.

How scores are computed

Pricing

Cleerly

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. The homepage offers a demo request.

Elucid

TierMonthlyAnnualNotes
Per analysisNot statedNot statedNo public price. Providers are billed per analysis. Category I CPT code 75577 has applied since January 1, 2026.

Evidence

Compliance and integrations

Documented from each vendor’s own pages.

SpecCleerlyElucid
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot statedNot stated
FoundedNot statedNot stated
HQUSNot stated

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.

See all radiology